A Study to Evaluate Denosumab in Young Patients With Primary Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Denosumab
Sponsor: Jules Bordet Institute
Collaborators: Melbourne Health